Georgia Cancer Study
The Georgia Cancer Study (GCS) of Emory University is funded by the Georgia Cancer Coalition (GCC), with a goal of enrolling 140,000 residents from the State of Georgia.
The GCS Principal Investigator, Roberd M. Bostick, MD, MPH leads a team of investigators and staff from the Rollins School of Public Health and School of Medicine.
The GCS pilot project, in partnership with community cancer coalitions, recruited approximately 750 participants from southwest and central Georgia counties to test the methodologies, questionnaires, specimen collection, and other aspects of the study.
Entry criteria include 25-74 years of age, no prior diagnosis of cancer*, and being a Georgia resident. Individuals who consent to participate have their height, weight, and blood pressures recorded, and also provide blood, urine, and saliva samples to be stored for investigations of potential biomarkers. Over time, the participants complete multiple questionnaires and maintain contact with GCS investigators. The GCS will enroll a diverse cross-section of Georgia residents.
*Note: You can still participate if your previous cancer diagnosis has been limited to cervical cancer in situ that was removed in a doctor’s office with no further treatment, or basal or squamous skin cancer removed completely with surgery and no further treatment.
Note: As of March 31, 2009, the Georgia Cancer Study has been suspended. Please click here for more information.
|Copyright © Emory University 2007. All rights reserved.|
|Emory Home | Directory | Search | Help | Employment | News | Events | Health Care | Lifelong Learning | Admissions | Visitors|